Protocol Ledger

Biopharma Industry · Consolidated Sponsor Hub

Bio-Thera Solutions: Clinical Trials & FDA Approval Profile

Bio-Thera Solutions (Global / Institutional) sponsors 20 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 7 active protocols (3 recruiting now), 7 completed protocols, and 2 all-time original FDA Drugs@FDA NDA and BLA approvals.

Primary Focus: Oncology and Hematology Interactive Workbench: Open Full Annual Timeline & Compare ->
Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)20.0%
Median Closed Enrollment vs National (145 pts)488 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Bio-Thera Solutions
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)20
Active Pipeline (Recruiting Now)7 (3)
Completed vs Stopped Early7 / 4 (20.0%)
Median Closed Actual Enrollment488 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals2 (2 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Bio-Thera Solutions
Hospital Research SiteLocationShared Protocols
Zhejiang Provincial People's HospitalHangzhou, Zhejiang4
Shenzhen People's HospitalShenzhen, Guangdong3
Peking University First HospitalBeijing, Beijing Municipality3

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Bio-Thera Solutions
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT07515079Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular EdemaPhase IIIRECRUITING
NCT06044350A Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum DisordersPhase IIACTIVE NOT RECRUITING
NCT05141994Clinical Study on the Efficacy and Safety of BAT5906 InjectionPhase IICOMPLETED
NCT05439629Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular DegenerationPhase IIICOMPLETED

Explore interactive annual charts and M&A subsidiary rollups in the Bio-Thera Solutions Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI